JP Morgan Upgrades Cabot to Overweight, Announces $62 Price Target

JP Morgan analyst Jeffrey Zekauskas upgrades Cabot (NYSE:CBT) from Neutral to Overweight and announces $62 price target.

byBenzinga Newsdesk

July 23, 2021

1 minute read

JP Morgan analyst Jeffrey Zekauskas upgrades Cabot (NYSE:CBT) from Neutral to Overweight and announces $62 price target.

Navidea’s Imaging Agent Can Distinguish Between Fibroid & Non-Fibroid Pathotype Of Rheumatoid Arthritis

By Vandana Singh

Today, 10:14 PM

Navidea Biopharmaceuticals Inc (NYSE:NAVB) announced preliminary results from the ongoing NAV3-32 Phase 2B study of Tc99m Tilmanocept imaging. The trial compared…

NAVB

Tesla A ‘Cornerstone Holding’ — But Usually-Bullish Analyst Cuts Price Target Again Anyway

By Shanthi Rexaline

Today, 10:14 PM

Tesla, Inc. (NASDAQ: TSLA) shares have not been spared in the marketwide selloff seen so far this year. In a further blow, an analyst known for being bullish on the EV maker lowered his price target on its stock.

TSLA

News

WarnerMedia Launches The WM Inclusive, A New Hub For All Things Culture And Content

By Benzinga Newsdesk

Today, 10:14 PM

Today WarnerMedia announced the launch of its new hub, WM Inclusive as the intersection of all things Equity + Inclusion across the company's diverse roster of brands, content and programming. The WM

National Bank Of Canada Downgrades Farmers Edge to Sector Perform

By Benzinga Newsdesk

Today, 10:14 PM

National Bank Of Canada downgrades Farmers Edge (OTC:FMEGF) from Outperform to Sector Perform.

FMEGF

JP Morgan Upgrades Cabot to Overweight, Announces $62 Price Target

Related Posts

Navidea’s Imaging Agent Can Distinguish Between Fibroid & Non-Fibroid Pathotype Of Rheumatoid Arthritis

Tesla A ‘Cornerstone Holding’ — But Usually-Bullish Analyst Cuts Price Target Again Anyway

WarnerMedia Launches The WM Inclusive, A New Hub For All Things Culture And Content

National Bank Of Canada Downgrades Farmers Edge to Sector Perform